Groups Urge HHS To Limit Burden In Conflict Of Interest Reg Proposal
This article was originally published in The Gray Sheet
Executive Summary
Industry and research organizations are worried that HHS proposals to change financial conflict of interest reporting regulations will cause undue administrative burden for health care research centers and privacy concerns for investigators
You may also be interested in...
NIH Conflict Of Interest Reg Attracts Criticism From Transparency Advocates
A new upgrade to the National Institutes of Health’s1995 regulations overseeing researcher conflict of interests is intended as “an insurance plan” against potential trouble downstream, NIH Director Francis Collins says. But a key change in the final rule compared to an earlier proposal is attracting criticism from transparency advocates.
NIH Conflict Of Interest Reg Attracts Criticism From Transparency Advocates
A new upgrade to the National Institutes of Health’s1995 regulations overseeing researcher conflict of interests is intended as “an insurance plan” against potential trouble downstream, NIH Director Francis Collins says. But a key change in the final rule compared to an earlier proposal is attracting criticism from transparency advocates.
Capitol Hill Briefs
FDA approps: The House passes 2010 FDA appropriations July 9, including a $35 million increase for CDRH from last year to well over $300 million. The Agriculture Appropriations Act includes $2.35 billion in total appropriations for FDA, a $299 million bump from 2009, equaling the Obama administration's request (1"The Gray Sheet" June 15, 2009). The Senate Appropriations Committee approved the same funding on July 7, but it still needs to be voted on by the full Senate